Thursday, 19 May, 2011
Pharma and Life Sciences Tax Webcast
Please register for a complimentary PricewaterhouseCoopers' Pharmaceutical and Life Sciences Tax Technical Hot Topics webcast on Thursday 19 May, 2011 from 12:00 PM - 1:30 PM (US EST). The webcast will be hosted by Michael Swanick, Global Pharmaceutical and Life Sciences Tax Leader and will cover the following topics:
-
Selected issues facing Pharmaceutical and Life Science companies in creating, developing and exploiting intellectual property within the United States and abroad
Today, companies face uncertainty and challenges in developing their intellectual property strategy. Pharmaceutical and Life Science companies create vast quantities of high-value intellectual property. As this intellectual property is created and exploited there are a multitude of issues to consider. This area has proven to be a point of contention between taxpayers and the IRS. Issues to be discussed will include the heightened focus on transfer pricing and intellectual property migration by U.S. regulatory authorities, U.S. legislative bodies, the Obama Administration, and the OECD.
-
Legislative landscape facing Pharmaceutical and Life Science companies.
As corporate tax reform is discussed in Washington, DC, companies need to understand the implications such reform proposals would have on their business. Issues to be discussed will include the various tax reform proposals, potential business and tax reporting impacts for companies and various revenue raising provisions.
-
Other Industry Issues
Much of the recent tax legislation has significantly impacted the Pharmaceutical & Life Science Industry, mostly notably the Patient Protection and Affordable Care Act. This discussion will briefly highlight other issues affecting Pharmaceutical and Life Science companies including the medical device excise tax, annual fee on branded prescription pharmaceuticals and Puerto Rico excise tax.
Who should participate?
Tax VPs/Directors and their tax teams, CFOs, controllers, COOs, finance directors, and senior supply chain executives in pharmaceutical, medical device and biotechnology companies.
Recommended CPE: application of 1.5 CPE taxation credit is in place.
Webcast Registration and Login
To enter the webcast, please log on to the following URL 15 minutes prior to the scheduled start time.
http://event.on24.com/r.htm?e=302203&s=1&k=99E6C381094E84318D8C2B9C108E179C
NOTE: Please make sure you can access the webcast in advance. If for any reason you cannot open the link/presentation, please contact Marina Bello Valcarce at marina.bello.valcarce@uk.pwc.com or Kathleen Un at kathleen.un@us.pwc.com.
Plain-English Accounting is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be addressed to the National Registry of CPE Sponsors, 150 Fourth Avenue North, Suite 700, Nashville, TN, 37219-2417. Web site: www.nasba.org
|
26 April, 2011
Pharma 2020: Supplying the future
In this Webcast, a panel of specialists will discuss significant changes the pharmaceutical supply chain is expected to undergo in the coming years and then explore potential scenarios for how pharmaceutical companies might restructure their supply chain strategy and operating models, depending on their unique product portfolio and channel strategy. The discussion will focus on the risks, opportunities and challenges in each of the four future supply chain models -- virtual manufacturer, service innovator, a mass market manufacturer or a profit center – identified by PwC in its groundbreaking report Pharma 2020: Supplying the Future: Which path will you take?
|
September 16, 2010
New Excise Taxes on Pharmaceutical and Medical Device Manufacturers and; New Irish Transfer Pricing Regulations for Global Pharmaceutical, Medical Device and Biotechnology Companies
Please register for a complimentary PwC's Pharmaceutical and Life Sciences Tax Technical Hot Topics webcast on Thursday 16 September, 2010 from 12:00 PM - 1:00 PM (US EST). The webcast was hosted by Michael Swanick, Global Pharmaceutical and Life Sciences Tax Leader and will cover the following two topics:
http://event.on24.com/eventRegistration/prereg/register.jsp?eventid=264994&sessionid=1&key=C09E88B87C7CA9E5BA8F0E14C2457874
|
May 25, 2010
Deciphering the initial Treasury guidance on Section 48D therapeutic discovery project credit,
On this webcast, a panel of PwC Life Science and Pharmaceutical industry specialists, National Tax, Economics and Government Grant specialists, as well as invited government speakers, discussed and assessed anticipated guidance on how companies may qualify and apply for the Section 48D therapeutic discovery project credit (or a grant in lieu of the credit).
The Webcast provided an initial overview of the Treasury guidance, a discussion of the programme's eligibility and selection criteria, and how the credit/grant application process works.
|
15 October, 2009
US healthcare reform: A briefing on the major business and tax impacts affecting pharmaceutical, medical device and biotechnology companies
Webcasts - Previous webcasts 
|
8 July, 2009
US Tax Reform Proposals and the New Irish Intellectual Property Rules - Impact on Pharma, Life Sciences and Medical Device Companies
|
7 May, 2009
Podcast: Update on China's changing pharmaceutical landscape
Michael Keech, director, Pharmaceutical and Life Sciences Advisory Services Group, being interviewed by Genetic Engineering News on the changing pharmaceutical landscape in China.
|
|
10 February, 2009
Audioconference: Sales & Marketing Disclosure Requirements
Update on Sales and Marketing Disclosure Requirements for Drug, Device and Biotech Companies
For more information, click here
|
|
27 January, 2009
IFRS conversion: Understanding the key tax issues for Pharmaceuticals, Life Sciences and Medical Devices companies
Key discussion topics include planning considerations and tax accounting method changes.
Archive
|
19 December, 2008
President-Elect Obama's Plans for Healthcare and Tax
Access the presentation - Adobe Acrobat file (201kb) |
|
